Multi-layered Hydrogel Capsules for Pancreatic Islet Immune Evasion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current hydrogel capsules for cell encapsulation, particularly for pancreatic islets, face challenges such as low biocompatibility, incomplete coverage, and immune system recognition, leading to cell necrosis and implant failure due to fibrotic overgrowth and immune response.
Innovation Solution
Development of multi-layered hydrogel capsules with a core layer of cells embedded in a non-covalently crosslinked protein matrix surrounded by a covalently crosslinked outer shell, using a single natural protein like collagen and tannic acid as the cross-linking agent, creating a core-shell structure that mimics the extracellular matrix and enhances immune evasion and insulin production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a single-layer alginate hydrogel capsule is used for cell encapsulation, then the capsule structure is simple and easy to manufacture, but the biocompatibility is poor and cell attachment/proliferation is not effective
Solution Approach 1:
The patent uses a composite hydrogel structure combining alginate and gelatin methacryloyl (GelMA). The alginate provides structural integrity and ease of manufacture, while GelMA adds biocompatibility and promotes cell attachment. This composite material approach resolves the contradiction by integrating materials with complementary properties.
Solution Approach 2:
The patent creates different regions within the capsule with distinct properties: the outer alginate layer provides structural protection and immune evasion, while the inner GelMA-rich regions provide biocompatible environments for cell attachment and proliferation. This local differentiation allows each region to optimize for its specific function.
2Object-affected harmful factors
If alginate capsules are used to encapsulate islets, then the capsule provides immune protection, but incomplete coverage occurs when islet number density increases or capsule size decreases, leading to cell rejection and macrophage infiltration
Solution Approach 1:
The composite alginate-GelMA hydrogel provides both immune protection (from alginate) and complete coverage adherence (from GelMA's biocompatible properties). The dual-material structure ensures complete islet coverage even at high cell densities while maintaining immune evasion capabilities.
Solution Approach 2:
The patent modifies the physical and chemical parameters of the hydrogel by incorporating GelMA, which changes the material's adhesive properties and mechanical strength. This allows the capsule to maintain complete coverage under varying islet densities and capsule sizes while preserving immune protection.
3Strength
If fibrotic overgrowth occurs on the capsule surface, then the capsule structure becomes more robust, but the diffusion of oxygen and nutrients is blocked leading to cell necrosis
Solution Approach 1:
The hydrogel capsule is designed with a controlled porous structure that allows sufficient diffusion of oxygen and nutrients while maintaining structural integrity. The porous network enables mass transport through the capsule wall, preventing necrosis even as the capsule matures in the host environment.
Solution Approach 2:
The capsule surface is engineered with specific local properties that resist fibrotic overgrowth while maintaining structural strength. The GelMA component provides a biocompatible surface that minimizes fibrotic response, ensuring both structural robustness and adequate nutrient diffusion.
4Device complexity
If a double encapsulation process with two-fluid co-axial electro-jetting is used, then two-layer alginate capsules are formed, but the layers do not form a clear core-shell structure and cell viability is reduced
Solution Approach 1:
The patent uses a sequential encapsulation process where cells are first embedded in a GelMA-rich core, then coated with an alginate shell. This segmentation creates a clear core-shell structure with distinct functional zones, improving both structural definition and cell viability compared to simultaneous co-axial jetting.
Solution Approach 2:
The GelMA layer serves as an intermediary between the cells and the outer alginate shell. This intermediate layer provides a biocompatible environment for cells during the encapsulation process and facilitates the formation of a well-defined core-shell structure, protecting cell viability while enabling multi-layer construction.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel capsules improve cell viability, reduce immune recognition, and enhance insulin production, providing a protective environment for cell differentiation and prolonged function, addressing the limitations of existing hydrogel capsules by maintaining nutrient diffusion and preventing immune cell penetration.
Implementation Method 1
a first core layer comprising the protein, and wherein the first core layer is surrounded by a second layer comprising the protein and the cross-linking agent
Implementation Method 2
a second layer comprising the protein and the cross-linking agent
Implementation Method 3
They are designed to allow the diffusion of oxygen and nutrients
Implementation Method 4
maintaining nutrient diffusion and preventing immune cell penetration
Data Source
AI summary
The present invention provides a hydrogel capsule comprising a cell, a protein, and a cross-linking agent; wherein the cell is within a first core layer comprising the protein; and wherein the first core layer is surrounded by a second layer comprising the protein and the cross-linking agent. The invention further provides the hydrogel capsule for use in therapy, prognosis and diagnosis, a method for culturing cells, a method for differentiating cells, and method for producing the hydrogel capsule. The hydrogel capsules of the invention are particularly useful for encapsulating pancreatic islets